Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer
Express Pharma
Akums develops moisturisation formulations for evolving skincare needs
Akums Drugs & Pharmaceuticals Ltd., a contract development and manufacturing organisation (CDMO), has introduced a portfolio of moisturisation formulations ahead of the winter skincare season. The formulations incorporate different ingredients […] The post Akums develops moisturisation formulations for evolving skincare needs appeared first on Express Pharma.
Read Full Article
Pharma Tech
FDA approves Teva’s monthly injection of olanzapine for schizophrenia
Teva said it is debuting the drug to overcome adherence issues with an oral counterpart and improve symptom outcomes.
Read Full Article
Pharma Tech
FDA approves Asahi Kasei’s Hovilpri for refractory HSV
The US FDA has approved Asahi Kasei Therapeutics’ Hovilpri 100mg tablets to treat refractory mucocutaneous HSV lesions in immunocompromised adults.
Read Full Article
Express Pharma
TDB approves ₹86 crore RDI support for Peptris’ AI-driven drug development
The VIGOR programme will advance four drug candidates from TRL-4 to TRL-6 over three years, covering preclinical development and preparation for clinical trials The post TDB approves ₹86 crore RDI support for Peptris’ AI-driven drug development appeared first on Express Pharma.
Read Full Article
Express Pharma
Cohance Lifesciences appoints Abhimanyu Ojha as CFO
Ojha joins as Chief Financial Officer and Key Managerial Personnel, effective October 12, 2026 The post Cohance Lifesciences appoints Abhimanyu Ojha as CFO appeared first on Express Pharma.
Read Full Article
Sponsored content
Featured promotional
News
Latest stories
ET Pharma
Oct 12, 2026, 2:01 PM
Cancer drug price cuts may vary despite 30% trade margin cap
The Centre’s 30 per cent cap on trade margins of non-scheduled anti-cancer drugs is expected to improve pricing transparency and narrow price gaps between competing generics. However, the impact on patient affordability may vary, as patented therapies leave less room for trade margin corrections.
PharmaShots
Oct 12, 2026, 12:24 PM
BMS Reports the P-III (ALOFT-IPF) Trial Data on Admilparant in Idiopathic Pulmonary Fibrosis
Shots: Ref: Businesswire |  Image: BMS  | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post BMS Reports the P-III (ALOFT-IPF) Trial Data on Admilparant in Idiopathic Pulmonary Fibrosis appeared first on PharmaShots.
PharmaShots
Oct 12, 2026, 11:30 AM
AstraZeneca Reports the P-III (HICKORY) Trial Data on Efzimfotase Alfa in Hypophosphatasia
Shots: Ref: AstraZeneca |  Image: AstraZeneca  | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post AstraZeneca Reports the P-III (HICKORY) Trial Data on Efzimfotase Alfa in Hypophosphatasia appeared first on PharmaShots.
Express Pharma
Oct 12, 2026, 10:54 AM
Akums develops moisturisation formulations for evolving skincare needs
Akums Drugs & Pharmaceuticals Ltd., a contract development and manufacturing organisation (CDMO), has introduced a portfolio of moisturisation formulations ahead of the winter skincare season. The formulations incorporate different ingredients […] The post Akums develops moisturisation formulations for evolving skincare needs appeared first on Express Pharma.
Pharma Tech
Oct 12, 2026, 10:48 AM
FDA approves Teva’s monthly injection of olanzapine for schizophrenia
Teva said it is debuting the drug to overcome adherence issues with an oral counterpart and improve symptom outcomes.
PharmaShots
Oct 12, 2026, 10:30 AM
Merck Reports the P-IIb/III (BRUNELLO) Trial Data on Remigromig for Diabetic Macular Edema
Shots: Ref: Businesswire |  Image: Merck  | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Merck Reports the P-IIb/III (BRUNELLO) Trial Data on Remigromig for Diabetic Macular Edema appeared first on PharmaShots.
News
Latest industry coverage
Google News
Oct 12, 2026, 8:53 PM
Particle Engineering Takes Center Stage as Pharmaceutical Formulation Science Moves Toward the Clinic - Bioengineer.org
Particle Engineering Takes Center Stage as Pharmaceutical Formulation Science Moves Toward the Clinic  Bioengineer.org
Google News
Oct 12, 2026, 8:00 PM
Greener Pharma Manufacturing Faces the Scale-Up Test - Environment+Energy Leader
Greener Pharma Manufacturing Faces the Scale-Up Test  Environment+Energy Leader
Google News
Oct 12, 2026, 7:41 PM
Biotech’s Rebound Reality: Surging M&A Deals Meet Deep Retail Skepticism - ETF Database
Biotech’s Rebound Reality: Surging M&A Deals Meet Deep Retail Skepticism  ETF Database
Google News
Oct 12, 2026, 7:19 PM
Is Eli Lilly (NYSE:LLY) Setting the Pace in Weight-Management Medicine? - Kalkine Media
Is Eli Lilly (NYSE:LLY) Setting the Pace in Weight-Management Medicine?  Kalkine Media
Google News
Oct 12, 2026, 7:07 PM
Kuwait eyes Algerian expertise in production and medical supplies - Kuwait Times
Kuwait eyes Algerian expertise in production and medical supplies  Kuwait Times
Google News
Oct 12, 2026, 7:01 PM
Teva Pharmaceutical Industries (NYSE:TEVA) Stock Price Target Raised at JPMorgan Chase & Co. - MarketBeat
Teva Pharmaceutical Industries (NYSE:TEVA) Stock Price Target Raised at JPMorgan Chase & Co.  MarketBeat
Google News
Oct 12, 2026, 6:39 PM
Particle Engineering and Formulation Science Drive Next-Generation Drug Dosage Forms - Bioengineer.org
Particle Engineering and Formulation Science Drive Next-Generation Drug Dosage Forms  Bioengineer.org
Google News
Oct 12, 2026, 5:57 PM
'Stay tuned for...': US envoy Sergio Gor on India-US ties after Modi-Trump talks - The Economic Times
'Stay tuned for...': US envoy Sergio Gor on India-US ties after Modi-Trump talks  The Economic Times
Google News
Oct 12, 2026, 5:53 PM
TEVA Stock Alert: What to Know as Teva Therapeutics' Scores FDA Approval for Schizophrenia Treament - Barchart.com
TEVA Stock Alert: What to Know as Teva Therapeutics' Scores FDA Approval for Schizophrenia Treament  Barchart.com
Sponsored placement
Featured promotions
Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer